These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 125321)

  • 21. A neutrophil immobilizing factor derived from human leukocytes. II. Specificity of action on polymorphonuclear leukocyte mobility.
    Goetzl EJ; Gigli I; Wasserman S; Austen KF
    J Immunol; 1973 Sep; 111(3):938-45. PubMed ID: 4741302
    [No Abstract]   [Full Text] [Related]  

  • 22. Defective neutrophil chemotaxis and cellular immunity in a child with recurrent infections.
    Clark RA; Root RK; Kimball HR; Kirkpatrick CH
    Ann Intern Med; 1973 Apr; 78(4):515-9. PubMed ID: 4571567
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased leukocyte glycogen in Down's syndrome.
    Abul-Fadl Y; Scott RB
    Nature; 1969 Jul; 223(5203):310-1. PubMed ID: 4240037
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein.
    Bowen TJ; Ochs HD; Altman LC; Price TH; Van Epps DE; Brautigan DL; Rosin RE; Perkins WD; Babior BM; Klebanoff SJ; Wedgwood RJ
    J Pediatr; 1982 Dec; 101(6):932-40. PubMed ID: 7143170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonspecific immunity in Down syndrome: a study of chemotaxis, phagocytosis, oxidative metabolism, and cell surface marker expression of polymorphonuclear cells.
    Novo E; García MI; Lavergne J
    Am J Med Genet; 1993 Jun; 46(4):384-91. PubMed ID: 7689298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biomedical study of Down's syndrome].
    Nakamura T
    Nihon Shonika Gakkai Zasshi; 1970 Mar; 74(3):400-11. PubMed ID: 4192691
    [No Abstract]   [Full Text] [Related]  

  • 27. Defective neutrophil chemotaxis with variant ichthyosis, hyperimmunoglobulinemia E, and recurrent infections.
    Pincus SH; Thomas IT; Clark RA; Ochs HD
    J Pediatr; 1975 Dec; 87(6 Pt 1):908-11. PubMed ID: 1185392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection, dermatitis, increased IgE, and impaired neutrophil chemotaxis. A possible relationship.
    Dahl MV; Greene WH; Quie PG
    Arch Dermatol; 1976 Oct; 112(10):1387-90. PubMed ID: 786175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil viability in Down's syndrome.
    Cocchi P; Silenzi M; Ravina A
    JAMA; 1978 Aug; 240(8):737. PubMed ID: 149866
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinicopathological findings in patients with primary and secondary defects of neutrophil mobility.
    Earhoudi A; Harvey BA; Soothill JF
    Arch Dis Child; 1978 Aug; 53(8):625-30. PubMed ID: 708097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Humoral and cellular immunity in children with Down's syndrome].
    Lukas A; Cesarz E; Lukas W; Sychłowy A; Sliwa F
    Pediatr Pol; 1980 Jan; 55(1):33-40. PubMed ID: 6445054
    [No Abstract]   [Full Text] [Related]  

  • 32. Leukocyte movement: experimental and clinical status. A current perspective.
    Miller ME
    Birth Defects Orig Artic Ser; 1975; 11(1):53-8. PubMed ID: 167884
    [No Abstract]   [Full Text] [Related]  

  • 33. Leucocyte function in Down's syndrome and acute leukaemia.
    Gregory L; Williams R; Thompson E
    Lancet; 1972 Jun; 1(7765):1359-61. PubMed ID: 4113564
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro stimulation of neutrophil motility by levamisole: maintenance of cgmp levels in chemotactically stimulated levamisole-treated neutrophils.
    Anderson R; Glover A; Koornhof HJ; Rabson AR
    J Immunol; 1976 Aug; 117(2):428-32. PubMed ID: 181491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocyte function and serum immunoglobulins in Down's syndrome.
    Rosner F; Kozinn PJ; Jervis GA
    N Y State J Med; 1973 Mar; 73(5):672-5. PubMed ID: 4265822
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter: Defective chemotaxis in measles patients.
    Anderson R; Sher R; Rabson AR; Koornhof HJ
    S Afr Med J; 1974 Sep; 48(43):1819-20. PubMed ID: 4608043
    [No Abstract]   [Full Text] [Related]  

  • 37. Granulocyte migration in vivo and in vitro in healthy children of parents with atopic asthma.
    Matusiewicz R; Rusiecka-Matusiewicz K
    Allergy; 1987 Apr; 42(3):173-6. PubMed ID: 3296842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of neutrophil chemotaxis in the pathogenesis of urinary tract infection.
    Khan AJ; Kumar K; Evans HE
    J Urol; 1987 Feb; 137(2):342-4. PubMed ID: 3543413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo assay of crevicular leukocyte migration. Its development and potential applications.
    Iacono VJ; Singh S; Golub LM; Ramamurthy NS; Kaslick R
    J Periodontol; 1985 Nov; 56(11 Suppl):56-62. PubMed ID: 2934540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophil surface protein markers as indicators of defective chemotaxis in LJP.
    Van Dyke TE; Warbington M; Gardner M; Offenbacher S
    J Periodontol; 1990 Mar; 61(3):180-4. PubMed ID: 2319438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.